Echinococcoses: A parasitic model for understanding allergic diseases?;Les échinococcoses: Un modèle parasitaire pour la compréhension des maladies allergiques ?

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 41, Issue 3, 2001, Pages 285-293

  Vuitton, D A ^a   Godot, V ^a   Harraga, S ^a   Liance, M ^a   Beurton, I ^b   Bresson Hadni, S ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

Atopic dermatitis; Cytokine; Echinococcosis; IL 10; Immunopathology

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 5; NITRIC OXIDE;

ALLERGIC DISEASE; ARTICLE; ATOPIC DERMATITIS; CELLULAR IMMUNITY; ECHINOCOCCOSIS; ECHINOCOCCUS; HYDATID CYST; IMMUNE RESPONSE; IMMUNOPATHOLOGY; PARASITOSIS; PATHOPHYSIOLOGY;

EID: 0035022755     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(01)00034-X     Document Type: Short Survey

References (82)

1. Prevalence of allergic diseases in patients with schistosomiasis mansoni
2. Does hyperimmunoglobulinemia-E protect tropical populations from allergic disease ?
3. Incidence of atopic disease in a tropical environment: Partial independence from intestinal helminthiasis
4. The high affinity receptor on eosinophils: From allergy to parasites or from parasites to allergy ?
5. CD4+ T-cell subsets: Regulation of differentiation and function
6. Role of type 2 T helper cells (Th2) in allergic disorders
7. Rôle des cytokines dans la réaction allergique inflammatoire
8. The Th1/Th2 paradigm and allergic disorders
9. Atopic allergy and other hypersensitivities interactions between genetic susceptibility, innocuous and/or microbial antigens and the immune system
10. Cytokines et chimiokines au cours de la désensibilisation
11. Cestodes. Echinococcus
12. Echinococcosis of the liver
13. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis
14. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparisons of patients with progressive and abortive lesions
15. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA BS, DR3, DQ2 haplotype
16. Modulation of human immune responses by Echinococcus granulosus antigen B and its possible role in evading immune host defenses
17. A twenty-year history of alveolar echinococcosis in humans. Analysis of a series of 117 patients from eastern France
18. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis
19. Hydroxypyridinum collagen cross-links in human liver fibrosis: Study of alveolar echinococcosis
20. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: Report of 17 cases
21. Primary disease recurrence after liver transplantation for alveolar echinococcosis: Long-term evaluation in 15 patients
22. Recurrence of alveolar echinococcosis in the liver graft after liver transplantation
23. Immunopathology of echinococcosis
24. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome
25. An epidemiological and ecological study of human alveolar echinococcosis transmission in South Gansu, China
26. Detection, screening and community epidemiology of taeniid cestode zoonoses: Cystic echinococcosis, alveolar echinococcosis and neurocysticercosis
27. Serological screening for Echinococcus multilocularis infections with ELISA
28. Comparison of serodiagnostic tests and ultrasonography for cystic hydatidosis in an epidemiological study of rural Uruguay
29. Cystic echinococcosis in semi-nomadic pastoral communities in Northwest China
30. Combined ultrasonographic and serological screening of hepatic alveolar echinococcosis in central China
31. Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis
32. Spontaneous death of Echinococcus multilocularis: Case diagnosed serologically (by Em2-Elisa) and clinical significance
33. Long-term outcome of asymptomatic liver hydatidosis
34. An extensive ultrasound and serologic study to investigate the prevalence of human cystic echinococcosis in northern Libya
35. Leprosy: Pathogenesis updated
36. In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients
37. Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis
38. Immunology and immunopathology of Echinococcus granulosus and Echinococcus multilocularis infection
39. Cellular immune response in Echinococcus multilocularis infection in humans. I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis
40. Soluble IL-2-receptor and CD8 in the serum and the periparasitic granuloma of patients with alveolar echinococcosis
41. Cellular localisations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis
42. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis
43. Cellular immunity in experimental Echinococcus multilocularis infection. II Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice
44. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis
45. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis
46. Interleukin (IL) -4, IL-10 and IL-12 profile in serum of patients with alveolar echinococcosis
47. Echinococcus multilocularis: Parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57BI/6J) or resistant (C57B1/10) to secondary alveolar echinococcosis
48. The effect of immunosuppression on secondary Echinococcus multilocularis infections in mice
49. Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis
50. Secondary Echinococcus multilocularis infection in severe combined immunodeficient (scid) mice: Biphasic growth of the larval cyst mass
51. Cellular immunity in experimental Echinococcus multilocularis infection. I. Sequential and comparative study of specific in vivo delayed-type hypersensitivity against E. multilocularis antigens in resistant and sensitive mice
52. Echinococcus multilocularis: Relationship between susceptibility/resistance of experimental mice and liver fibrogenesis
53. Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice
54. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis
55. Secondary alveolar echinococcosis in lymphotoxin and tumour necrosis factor deficient mice: Exacerbation of Echinococcus multilocularis. Larval growth is associated with cellular changes in the granuloma
56. Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection
57. Echinococcosis
58. Immune recognition of Echinococcus granulosus. 1. Parasite-activated, primary transformation by normal murine lymph node cell
59. Echinococcus granulosus: Assays for hydatid immunoregulatory factors using established lymphoid cell lines
60. Growth kinetics of leukocyte cell lines cultured with hydatid fluid of Echinococcus granulosus equinus
61. HLA and alveolar echinococcosis
62. The immunogenetics of human infectious diseases
63. Trois observations familiales d'échinococcose alvéolaire
64. Association of HLA-DRBI allele and the susceptibility to alveolar echinococcosis in West of China [en chinois]
65. Life cycle patterns and geographic distribution of Echinococcus species
66. Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies
67. Lack of H-2 gene influence on mouse susceptibility to secondary alveolar echinococcosis
68. BCG suppresses growth and metastasis of hydatid infections
69. Echinococcus multilocularis infection in mice: In vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis
70. Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis
71. Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: Case report
72. Treatment of experimental alveolar echinococcosis: Comparative study of mebendazole, isoprinosine and a mebendazole isoprinosine association
73. Effects of multiple doses of isoprinosine on Echinococcus multilocularis metacestodes
74. Echinococcus granulosus: Isoprinosine treatment of the metacestode stage
75. Effects of isoprinosine on Echinococcus multilocularis and E. granulosus metacestodes
76. Clinical efficacy of and switch from T helper 2 to T helper I cytokine profile after interferon alpha2a monotherapy for human echinococcosis
77. Effects of rIFNα-2a treatment on the functions of peritoneal macrophages in E. multilocularis infected C57BL/6J mice
78. Atopic dermatitis: From the genes to skin lesions
79. The environment and sensitisation to allergens in early childhood
80. Immune responses during pregnancy and the development of allergic disease